Spectacle Lens Visual Acuity Assessments Study

N/AActive Not RecruitingNCT05650190

SightGlass Vision, Inc.51 enrolled

Overview

This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Myopia Myopia Progression Juvenile Myopia

Interventions

Novel spectacle lens designDEVICE

Use of single vision, impact resistant spectacle lenses may reduce the rate of progression of juvenile myopia

Spectacle lensesDEVICE

Single vision, impact resistant spectacle lenses

Eligibility

Sex: ALLMin age: 9 YearsMax age: 14 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Existing subject from the CYPRESS Extension study (CPRO-1802-002) * Ability to comply with study assessments * The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed coy of the form Exclusion Criteria: * Any current ocular infection, inflammation or irritation likely to affect vision

Locations (6)

Sabal Eye Care

Longwood, Florida, United States

Kannarr Eye Care

Pittsburg, Kansas, United States

Advanced Eyecare PC

Raytown, Missouri, United States

SUNY School of Optometry

New York, New York, United States

Outcomes

Primary Outcomes

Visual Acuity

Reading Speed (maximum words per minute)

Time frame: 15 minutes

Secondary Outcomes

Near Visual Acuity with Glare

Mean and Standard Deviation at 15 minutes (short duration test)

Time frame: 15 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.